Company intelligence / Profile preview

Healint

Ownership: Private
Development stage: Commercial

Overview

Healint’s platforms have demonstrated large-scale adoption in migraine tracking (>3 million users), generated over 100 million tracked migraine days, supported real-world evidence generation, and enabled virtual clinical trials. The company has collaborated with leading academic centers to validate its AI-driven diagnostic tools for headache/migraine.[4][6]

Therapeutic areas: Neurology
Modalities: Device (mobile app)Non-pharmacological therapy (digital health intervention)Artificial intelligence-based software as a medical device (SaMD)
Industry: Digital Health Medical Devices

Drug pipeline

2 assets

Migraine Buddy

Commercial

Indications: Migraine

1 more asset in the full pipeline.

Request access →

Partnerships

Nestlé Health ScienceNovartisNYUKing’s College LondonSaitama Medical University Hospital JapanUniversity of Geneva Switzerland

Beyond the preview

Go deeper on Healint.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Healint.

Explore the full profile